Nidia Calero
Concepts (274)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Ischemia | 15 | 2025 | 358 | 2.120 |
Why?
| | Hippocampus | 20 | 2025 | 965 | 1.680 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 7 | 2025 | 196 | 1.680 |
Why?
| | Anesthetics | 3 | 2022 | 99 | 1.580 |
Why?
| | Heart Arrest | 13 | 2025 | 407 | 1.420 |
Why?
| | TRPM Cation Channels | 7 | 2024 | 75 | 1.190 |
Why?
| | Neurotoxicity Syndromes | 5 | 2025 | 38 | 1.160 |
Why?
| | Purkinje Cells | 4 | 2019 | 64 | 1.080 |
Why?
| | Neurons | 16 | 2025 | 1640 | 1.010 |
Why?
| | Microglia | 3 | 2025 | 268 | 0.860 |
Why?
| | Memory | 2 | 2023 | 295 | 0.830 |
Why?
| | Long-Term Potentiation | 5 | 2025 | 200 | 0.790 |
Why?
| | Cardiopulmonary Resuscitation | 8 | 2025 | 340 | 0.790 |
Why?
| | Anesthetics, Inhalation | 3 | 2025 | 52 | 0.770 |
Why?
| | Stroke | 7 | 2023 | 1256 | 0.740 |
Why?
| | Animals | 53 | 2025 | 38058 | 0.720 |
Why?
| | Gonadal Steroid Hormones | 2 | 2025 | 144 | 0.700 |
Why?
| | Neuronal Plasticity | 6 | 2021 | 309 | 0.690 |
Why?
| | Ketamine | 1 | 2022 | 132 | 0.680 |
Why?
| | Recovery of Function | 6 | 2025 | 707 | 0.670 |
Why?
| | Mice | 36 | 2025 | 18339 | 0.640 |
Why?
| | Brain | 6 | 2021 | 2933 | 0.640 |
Why?
| | Solute Carrier Family 12, Member 2 | 1 | 2019 | 7 | 0.610 |
Why?
| | Genes, Immediate-Early | 1 | 2019 | 26 | 0.610 |
Why?
| | Dendritic Spines | 3 | 2025 | 69 | 0.610 |
Why?
| | Neuroprotective Agents | 7 | 2020 | 143 | 0.610 |
Why?
| | Brain Injuries | 3 | 2025 | 507 | 0.600 |
Why?
| | Protective Agents | 1 | 2019 | 42 | 0.600 |
Why?
| | Calmodulin | 1 | 2019 | 70 | 0.600 |
Why?
| | Cations | 1 | 2019 | 82 | 0.600 |
Why?
| | Symporters | 1 | 2019 | 48 | 0.590 |
Why?
| | Chlorides | 1 | 2019 | 142 | 0.570 |
Why?
| | Holoenzymes | 1 | 2018 | 25 | 0.550 |
Why?
| | Mice, Inbred C57BL | 23 | 2025 | 5992 | 0.550 |
Why?
| | Burns | 2 | 2023 | 377 | 0.540 |
Why?
| | Sex Characteristics | 5 | 2020 | 790 | 0.510 |
Why?
| | Brain Injuries, Traumatic | 2 | 2023 | 441 | 0.480 |
Why?
| | Neurodevelopmental Disorders | 1 | 2020 | 227 | 0.480 |
Why?
| | Receptors, GABA-A | 5 | 2024 | 138 | 0.480 |
Why?
| | Animals, Newborn | 6 | 2025 | 902 | 0.460 |
Why?
| | CA1 Region, Hippocampal | 4 | 2024 | 51 | 0.440 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 4 | 2020 | 226 | 0.420 |
Why?
| | Calcium | 2 | 2019 | 1183 | 0.410 |
Why?
| | Cognition Disorders | 3 | 2020 | 538 | 0.390 |
Why?
| | Androgens | 2 | 2014 | 186 | 0.360 |
Why?
| | Disease Models, Animal | 12 | 2025 | 4557 | 0.350 |
Why?
| | Methyl Ethers | 2 | 2023 | 19 | 0.350 |
Why?
| | Synapses | 4 | 2022 | 439 | 0.350 |
Why?
| | Astrocytes | 1 | 2022 | 222 | 0.320 |
Why?
| | Rats, Sprague-Dawley | 7 | 2025 | 2527 | 0.320 |
Why?
| | Morphine | 3 | 2011 | 168 | 0.310 |
Why?
| | Narcotics | 2 | 2011 | 55 | 0.300 |
Why?
| | Neuroprotection | 3 | 2020 | 46 | 0.300 |
Why?
| | Receptors, Opioid, mu | 2 | 2011 | 68 | 0.300 |
Why?
| | Alzheimer Disease | 1 | 2025 | 621 | 0.280 |
Why?
| | Age Factors | 3 | 2022 | 3333 | 0.260 |
Why?
| | Rats | 7 | 2025 | 5597 | 0.260 |
Why?
| | Male | 30 | 2025 | 72315 | 0.250 |
Why?
| | Child Development | 1 | 2022 | 484 | 0.250 |
Why?
| | Inflammation | 3 | 2025 | 2878 | 0.250 |
Why?
| | Arrestin | 1 | 2006 | 14 | 0.240 |
Why?
| | Ischemia | 2 | 2020 | 421 | 0.240 |
Why?
| | Rhodopsin | 1 | 2006 | 11 | 0.240 |
Why?
| | Infarction, Middle Cerebral Artery | 2 | 2023 | 41 | 0.240 |
Why?
| | Cell Death | 6 | 2020 | 383 | 0.230 |
Why?
| | Lipopolysaccharides | 2 | 2025 | 863 | 0.230 |
Why?
| | Sirtuin 2 | 1 | 2015 | 27 | 0.230 |
Why?
| | Microbiota | 1 | 2023 | 781 | 0.230 |
Why?
| | Signal Transduction | 6 | 2024 | 5226 | 0.220 |
Why?
| | Phosphorylation | 6 | 2023 | 1732 | 0.210 |
Why?
| | Small-Conductance Calcium-Activated Potassium Channels | 1 | 2014 | 13 | 0.210 |
Why?
| | Mice, Knockout | 8 | 2019 | 3121 | 0.210 |
Why?
| | Receptors, Adrenergic, alpha-2 | 1 | 2013 | 11 | 0.200 |
Why?
| | Apoptosis | 4 | 2025 | 2430 | 0.200 |
Why?
| | Glycosaminoglycans | 1 | 2023 | 74 | 0.200 |
Why?
| | Alternative Splicing | 1 | 2006 | 247 | 0.200 |
Why?
| | Adrenergic alpha-2 Receptor Agonists | 1 | 2013 | 25 | 0.200 |
Why?
| | Dexmedetomidine | 1 | 2013 | 44 | 0.190 |
Why?
| | Mossy Fibers, Hippocampal | 1 | 2022 | 10 | 0.190 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2013 | 86 | 0.190 |
Why?
| | Spinal Cord Ischemia | 1 | 2013 | 60 | 0.190 |
Why?
| | Neurocognitive Disorders | 1 | 2022 | 33 | 0.180 |
Why?
| | Methadone | 2 | 2011 | 121 | 0.180 |
Why?
| | Anesthetics, General | 1 | 2022 | 14 | 0.180 |
Why?
| | Cerebellar Diseases | 1 | 2022 | 27 | 0.180 |
Why?
| | Nerve Net | 2 | 2022 | 285 | 0.180 |
Why?
| | Locus Coeruleus | 2 | 2008 | 24 | 0.170 |
Why?
| | Brain-Derived Neurotrophic Factor | 2 | 2018 | 148 | 0.170 |
Why?
| | Sex Factors | 4 | 2018 | 2112 | 0.170 |
Why?
| | Models, Animal | 1 | 2013 | 392 | 0.170 |
Why?
| | Presynaptic Terminals | 1 | 2021 | 86 | 0.170 |
Why?
| | Spinal Cord | 1 | 2013 | 380 | 0.160 |
Why?
| | Genetic Variation | 1 | 2006 | 983 | 0.160 |
Why?
| | Reperfusion Injury | 1 | 2013 | 300 | 0.160 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2015 | 383 | 0.160 |
Why?
| | Cell-Derived Microparticles | 1 | 2021 | 75 | 0.160 |
Why?
| | Synaptic Transmission | 1 | 2022 | 290 | 0.160 |
Why?
| | Pregnanediones | 1 | 2020 | 12 | 0.160 |
Why?
| | Oxygen | 2 | 2012 | 995 | 0.160 |
Why?
| | Death-Associated Protein Kinases | 1 | 2020 | 10 | 0.160 |
Why?
| | Estrogens | 1 | 2013 | 380 | 0.150 |
Why?
| | Long-Term Synaptic Depression | 2 | 2018 | 51 | 0.150 |
Why?
| | Reflex, Righting | 1 | 2019 | 15 | 0.150 |
Why?
| | Protein Transport | 2 | 2018 | 441 | 0.150 |
Why?
| | Cognition | 1 | 2017 | 1266 | 0.150 |
Why?
| | Steroids | 1 | 2020 | 160 | 0.150 |
Why?
| | Peptides | 2 | 2023 | 995 | 0.140 |
Why?
| | Extracellular Vesicles | 1 | 2021 | 171 | 0.140 |
Why?
| | G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 2008 | 10 | 0.140 |
Why?
| | Female | 16 | 2025 | 78271 | 0.140 |
Why?
| | Thalamic Nuclei | 1 | 2018 | 9 | 0.140 |
Why?
| | Hypnotics and Sedatives | 1 | 2020 | 216 | 0.130 |
Why?
| | Peptide Fragments | 1 | 2021 | 699 | 0.130 |
Why?
| | Membrane Potentials | 1 | 2008 | 280 | 0.130 |
Why?
| | Calcium Signaling | 1 | 2019 | 251 | 0.130 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2018 | 269 | 0.130 |
Why?
| | Exons | 1 | 2018 | 358 | 0.120 |
Why?
| | Protein Isoforms | 1 | 2018 | 402 | 0.120 |
Why?
| | Up-Regulation | 1 | 2019 | 851 | 0.120 |
Why?
| | Protein Domains | 1 | 2018 | 313 | 0.120 |
Why?
| | Excitatory Postsynaptic Potentials | 1 | 2016 | 117 | 0.120 |
Why?
| | Time Factors | 6 | 2017 | 7173 | 0.110 |
Why?
| | Membrane Glycoproteins | 1 | 2018 | 496 | 0.110 |
Why?
| | RGS Proteins | 2 | 2006 | 17 | 0.110 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2020 | 428 | 0.110 |
Why?
| | Mice, Transgenic | 5 | 2011 | 2182 | 0.110 |
Why?
| | Aging | 2 | 2013 | 1966 | 0.110 |
Why?
| | Membrane Proteins | 1 | 2021 | 1166 | 0.110 |
Why?
| | Learning | 1 | 2019 | 452 | 0.110 |
Why?
| | Estradiol | 1 | 2018 | 533 | 0.110 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2018 | 433 | 0.110 |
Why?
| | DNA Methylation | 1 | 2020 | 681 | 0.110 |
Why?
| | Humans | 15 | 2025 | 144759 | 0.110 |
Why?
| | Cerebral Cortex | 1 | 2018 | 464 | 0.110 |
Why?
| | Retina | 3 | 2006 | 324 | 0.100 |
Why?
| | Cognitive Dysfunction | 1 | 2019 | 461 | 0.100 |
Why?
| | Chemokines | 1 | 2023 | 218 | 0.090 |
Why?
| | Postoperative Complications | 1 | 2015 | 2919 | 0.090 |
Why?
| | Anxiety | 1 | 2020 | 1109 | 0.090 |
Why?
| | Dysbiosis | 1 | 2023 | 187 | 0.090 |
Why?
| | Ligands | 1 | 2023 | 673 | 0.090 |
Why?
| | Calcineurin | 2 | 2023 | 105 | 0.080 |
Why?
| | Mitochondria | 2 | 2022 | 984 | 0.080 |
Why?
| | Colon | 1 | 2023 | 304 | 0.080 |
Why?
| | Swine | 1 | 2023 | 833 | 0.080 |
Why?
| | Photic Stimulation | 3 | 2006 | 264 | 0.080 |
Why?
| | Receptors, AMPA | 2 | 2018 | 147 | 0.080 |
Why?
| | Patch-Clamp Techniques | 2 | 2012 | 289 | 0.080 |
Why?
| | RNA, Messenger | 1 | 2018 | 2832 | 0.080 |
Why?
| | In Vitro Techniques | 3 | 2006 | 1047 | 0.080 |
Why?
| | Oxidative Stress | 2 | 2016 | 1339 | 0.070 |
Why?
| | Epigenesis, Genetic | 1 | 2022 | 684 | 0.060 |
Why?
| | Retinal Rod Photoreceptor Cells | 1 | 2006 | 17 | 0.060 |
Why?
| | Bacteria | 1 | 2023 | 889 | 0.060 |
Why?
| | Memory Disorders | 1 | 2017 | 193 | 0.060 |
Why?
| | Glucose | 2 | 2012 | 1047 | 0.060 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2017 | 192 | 0.060 |
Why?
| | Furans | 1 | 2015 | 27 | 0.060 |
Why?
| | Mice, Inbred DBA | 1 | 2006 | 187 | 0.060 |
Why?
| | Child | 4 | 2023 | 22633 | 0.060 |
Why?
| | HEK293 Cells | 2 | 2020 | 744 | 0.060 |
Why?
| | Calbindins | 1 | 2014 | 6 | 0.050 |
Why?
| | Monitoring, Intraoperative | 1 | 2015 | 64 | 0.050 |
Why?
| | Pregnancy | 1 | 2018 | 7190 | 0.050 |
Why?
| | Dizocilpine Maleate | 1 | 2014 | 24 | 0.050 |
Why?
| | Calcium Channel Agonists | 1 | 2014 | 12 | 0.050 |
Why?
| | Cells, Cultured | 2 | 2013 | 4154 | 0.050 |
Why?
| | Tissue Culture Techniques | 1 | 2014 | 83 | 0.050 |
Why?
| | Ovariectomy | 1 | 2025 | 162 | 0.050 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2014 | 107 | 0.050 |
Why?
| | Cell Communication | 1 | 2016 | 324 | 0.050 |
Why?
| | Quinolines | 1 | 2015 | 193 | 0.050 |
Why?
| | Blotting, Western | 2 | 2012 | 1187 | 0.050 |
Why?
| | Decorin | 1 | 2023 | 7 | 0.050 |
Why?
| | Hematoxylin | 1 | 2013 | 8 | 0.050 |
Why?
| | Eosine Yellowish-(YS) | 1 | 2013 | 10 | 0.050 |
Why?
| | Fluoresceins | 1 | 2013 | 48 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2020 | 2027 | 0.050 |
Why?
| | GABAergic Neurons | 1 | 2024 | 35 | 0.050 |
Why?
| | Constriction | 1 | 2013 | 47 | 0.050 |
Why?
| | Chondroitin Sulfates | 1 | 2023 | 35 | 0.050 |
Why?
| | CREB-Binding Protein | 1 | 2013 | 34 | 0.050 |
Why?
| | Dihydrotestosterone | 1 | 2013 | 42 | 0.050 |
Why?
| | GTP Phosphohydrolases | 1 | 2003 | 93 | 0.050 |
Why?
| | Orchiectomy | 1 | 2013 | 74 | 0.050 |
Why?
| | Aspartic Acid Endopeptidases | 1 | 2023 | 32 | 0.050 |
Why?
| | Benzimidazoles | 1 | 2014 | 190 | 0.050 |
Why?
| | bcl-2-Associated X Protein | 1 | 2013 | 54 | 0.050 |
Why?
| | Piperidines | 1 | 2014 | 217 | 0.050 |
Why?
| | Neural Inhibition | 1 | 2024 | 178 | 0.050 |
Why?
| | Amyloid beta-Protein Precursor | 1 | 2023 | 64 | 0.050 |
Why?
| | Poly (ADP-Ribose) Polymerase-1 | 1 | 2013 | 53 | 0.050 |
Why?
| | Primary Cell Culture | 1 | 2013 | 173 | 0.050 |
Why?
| | Extracellular Matrix Proteins | 1 | 2023 | 158 | 0.050 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2023 | 77 | 0.050 |
Why?
| | Hypothermia, Induced | 1 | 2013 | 96 | 0.050 |
Why?
| | Electrophysiology | 2 | 2008 | 218 | 0.050 |
Why?
| | Caspase 9 | 1 | 2022 | 55 | 0.050 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 341 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2013 | 240 | 0.050 |
Why?
| | Receptors, Androgen | 1 | 2013 | 153 | 0.040 |
Why?
| | Corpus Striatum | 1 | 2013 | 179 | 0.040 |
Why?
| | Caspase 1 | 1 | 2022 | 148 | 0.040 |
Why?
| | Clotrimazole | 1 | 2011 | 3 | 0.040 |
Why?
| | beta-Arrestin 2 | 1 | 2011 | 7 | 0.040 |
Why?
| | Organ Culture Techniques | 1 | 2021 | 154 | 0.040 |
Why?
| | Gene Expression | 1 | 2006 | 1490 | 0.040 |
Why?
| | Caspase 3 | 1 | 2022 | 238 | 0.040 |
Why?
| | Microinjections | 1 | 2011 | 92 | 0.040 |
Why?
| | G-Protein-Coupled Receptor Kinase 2 | 1 | 2011 | 9 | 0.040 |
Why?
| | beta-Arrestins | 1 | 2011 | 14 | 0.040 |
Why?
| | Arrestins | 1 | 2011 | 14 | 0.040 |
Why?
| | Lentivirus | 1 | 2011 | 60 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2013 | 436 | 0.040 |
Why?
| | Myelin Sheath | 1 | 2023 | 168 | 0.040 |
Why?
| | Interleukin-18 | 1 | 2022 | 235 | 0.040 |
Why?
| | Culture Media | 1 | 2011 | 161 | 0.040 |
Why?
| | Aorta, Thoracic | 1 | 2013 | 286 | 0.040 |
Why?
| | Brain Chemistry | 1 | 2011 | 116 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2014 | 592 | 0.040 |
Why?
| | Oligodendroglia | 1 | 2023 | 187 | 0.040 |
Why?
| | Mammals | 1 | 2022 | 293 | 0.040 |
Why?
| | Amyloid beta-Peptides | 1 | 2023 | 241 | 0.040 |
Why?
| | GABA-A Receptor Agonists | 1 | 2020 | 17 | 0.040 |
Why?
| | Cell Hypoxia | 1 | 2011 | 247 | 0.040 |
Why?
| | Endocytosis | 1 | 2011 | 168 | 0.040 |
Why?
| | Cerebellum | 1 | 2022 | 223 | 0.040 |
Why?
| | Neurotoxins | 1 | 2020 | 28 | 0.040 |
Why?
| | Inhibitory Postsynaptic Potentials | 1 | 2020 | 48 | 0.040 |
Why?
| | Genetic Vectors | 1 | 2011 | 337 | 0.040 |
Why?
| | Polymerase Chain Reaction | 1 | 2012 | 1054 | 0.040 |
Why?
| | Models, Theoretical | 1 | 2023 | 582 | 0.040 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2019 | 72 | 0.040 |
Why?
| | Propofol | 1 | 2020 | 85 | 0.040 |
Why?
| | RNA, Small Interfering | 1 | 2011 | 635 | 0.040 |
Why?
| | Etorphine | 1 | 2008 | 2 | 0.040 |
Why?
| | Cardiac Surgical Procedures | 1 | 2015 | 609 | 0.040 |
Why?
| | Fluorescent Antibody Technique, Direct | 1 | 2008 | 9 | 0.040 |
Why?
| | Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 2008 | 11 | 0.040 |
Why?
| | Oxymorphone | 1 | 2008 | 5 | 0.040 |
Why?
| | Colforsin | 1 | 2008 | 48 | 0.040 |
Why?
| | Radioligand Assay | 1 | 2008 | 37 | 0.040 |
Why?
| | Egtazic Acid | 1 | 2008 | 38 | 0.040 |
Why?
| | Immunohistochemistry | 1 | 2012 | 1716 | 0.040 |
Why?
| | Cell Culture Techniques | 1 | 2011 | 375 | 0.030 |
Why?
| | Chelating Agents | 1 | 2008 | 71 | 0.030 |
Why?
| | Receptor, trkB | 1 | 2018 | 36 | 0.030 |
Why?
| | Oxycodone | 1 | 2008 | 53 | 0.030 |
Why?
| | Glutamic Acid | 1 | 2020 | 251 | 0.030 |
Why?
| | Cyclic AMP | 1 | 2008 | 209 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2013 | 905 | 0.030 |
Why?
| | Receptors, Glutamate | 1 | 2016 | 26 | 0.030 |
Why?
| | Resuscitation | 1 | 2020 | 302 | 0.030 |
Why?
| | Prefrontal Cortex | 1 | 2020 | 328 | 0.030 |
Why?
| | Brain Infarction | 1 | 2016 | 23 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 2008 | 675 | 0.030 |
Why?
| | GTP-Binding Protein beta Subunits | 2 | 2006 | 17 | 0.030 |
Why?
| | Pediatrics | 1 | 2013 | 1114 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2021 | 869 | 0.030 |
Why?
| | Cytokines | 1 | 2022 | 2061 | 0.030 |
Why?
| | Transfection | 1 | 2016 | 940 | 0.030 |
Why?
| | Protein Binding | 1 | 2020 | 2273 | 0.020 |
Why?
| | Aged | 1 | 2023 | 25913 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2015 | 11679 | 0.020 |
Why?
| | Analgesics, Opioid | 1 | 2008 | 1143 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2022 | 3863 | 0.020 |
Why?
| | Mutation | 1 | 2020 | 4089 | 0.020 |
Why?
| | G-Protein-Coupled Receptor Kinase 1 | 1 | 2006 | 1 | 0.020 |
Why?
| | Vision, Ocular | 1 | 2006 | 47 | 0.020 |
Why?
| | Subcellular Fractions | 1 | 2003 | 74 | 0.010 |
Why?
| | Light | 1 | 2006 | 411 | 0.010 |
Why?
| | Macromolecular Substances | 1 | 2003 | 224 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2003 | 862 | 0.010 |
Why?
| | Adult | 1 | 2014 | 40449 | 0.010 |
Why?
|
|
Calero's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|